For research use only. Not for therapeutic Use.
GNF4877 (Cat No.: I017791) is an experimental small molecule being investigated for its potential in treating cancer. It acts as an inhibitor of specific kinases involved in cancer cell proliferation and survival. By targeting these kinases, GNF4877 aims to disrupt cancer cell growth and reduce tumor progression. Early preclinical studies have shown promise in its ability to inhibit tumor growth in various cancer models. Ongoing research is focused on evaluating its safety, efficacy, and potential as a targeted therapy for treating different types of cancer.
CAS Number | 2041073-22-5 |
Molecular Formula | C₂₅H₂₇FN₆O₄ |
Purity | ≥95% |
Target | Stem Cell/Wnt |
Reference | [1]. Shen W, et al. Inhibition of DYRK1A and GSK3β induces human β-cell proliferation. Nat Commun. 2015 Oct 26;6:8372. |